Burkitt's Lymphoma-Leukemia in Patients Treated for Hodgkin's Disease

References

• Henry-Amar M, Dietrich P Y. Acute leukemia after the treatment of Hodgkin's disease. Hematol Oncol Clin North Am 1993; 7: 369–387
   PubMed Web of Science ®Google Scholar
• Tucker M A. Solid second cancers following Hodgkin's disease. Hematol Oncol Clin North Am 1993; 7: 389–400
   PubMed Web of Science ®Google Scholar
• Lacher M J, Sussman L N. Leukemia and Hodgkin's disease. Ann Intern Med 1963; 59: 369–378
   PubMed Web of Science ®Google Scholar
• Mathe G, Tubiana M, Caiman F, et al. Les syndromes de leucemies aigues (SLA) apparaissant au cours de l'evolution des hematosarcomes et des leucemies chroniques (Analyse clinique). Nouv Rev Franc Hematol 1967; 7: 543–557
   PubMedGoogle Scholar
• Burns C P, Stjernholm R L, Kellermeyer R W. Hodgkin's disease terminating in acute lymphosarcoma leukemia: A metabolic study. Cancer 1971; 27: 806–811
   PubMed Web of Science ®Google Scholar
• Chan B W, McBride J A. Hodgkin's disease and leukemia. Can Med Assoc J 1972; 106: 558–601
   PubMed Web of Science ®Google Scholar
• Falkson H L, Portugal M A, Falkson G. Leukaemia in Hodgkin's disease. S Afr Med J 1976; 50: 1429–1431
   PubMedGoogle Scholar
• Dick F R, Maca R D, Hanhenson R. Hodgkin's disease terminating in a T-cell immunoblastic leukemia. Cancer 1978; 42: 1325–1329
   PubMed Web of Science ®Google Scholar
• Boucheix C, Zittoun R, Reynes M, et al. Atypical T-cell leukenùa terminating Hodgkin's disease. Cancer 1979; 44: 1403–1407
   PubMed Web of Science ®Google Scholar
• Auclerc G, Jacquillat C, Auclerc M F, et al. Post therapeutic acute leukemia. Cancer 1979; 44: 2017–2025
   PubMed Web of Science ®Google Scholar
• Saleem A, Johnston R L. Acute lymphoblastic leukemia following Hodgkin's disease. Ann Clin Lab Sci 1980; 10: 100–104
   PubMed Web of Science ®Google Scholar
• Arkin C F, Kurtz S R, Sparks J T. Acute B-cell leukemia occurring with Hodgkin's disease. Am J Clin Pathol 1981; 75: 406–410
   PubMed Web of Science ®Google Scholar
• Armitage J O, Dick F R, Goeken J A, et al. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. Arch Intern Med 1983; 143: 445–450
   PubMed Web of Science ®Google Scholar
• Zamora P, Feliu J, de Paredes Garcia ML, et al. Leucosis aguda linfoblastica tras enfermedadde Hodgkin. Med Clin (Bare) 1986; 87: 216–217
   PubMedGoogle Scholar
• Sonneveld P, Hagemeiger A, Abels J. Acute lymphoblastic leukaemia occurring 6 years after treatment of Hodgkin's disease. Br J Haematol 1988; 68: 261–262
   PubMed Web of Science ®Google Scholar
• van Leeuwen F E, Somers R, Taal B G, et al. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. J Clin Oncol 1989; 7: 1046–1058
   PubMed Web of Science ®Google Scholar
• Kaldor J M, Day N E, Clarke E A, et al. Leukemia following Hodgkin's disease. N Engl J Med 1990; 322: 7–13
   PubMed Web of Science ®Google Scholar
• Narayanan M N, Morgenstern G R, Chang G C, et al. Acute lymphoblastic leukaemia following Hodgkin's disease is associated with a good prognosis. Br J Haematol 1994; 86: 867–869
   PubMed Web of Science ®Google Scholar
• Devereux S, Selassie T G, Hudson Vaughan G, et al. Leukaemia complicating treatment for Hodgkin's disease: The experience of the British National Lymphoma Investigation. Br Med J 1990; 301: 1077–1080
   PubMed Web of Science ®Google Scholar
• Magrath I, Henle W, Owor R, et al. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease. N Engl J Med 1975; 292: 621–623
   PubMed Web of Science ®Google Scholar
• Case Records of the Massachusetts General Hospital (Case 6–1980). N Engl J Med 1980; 302: 389–395
   PubMedGoogle Scholar
• Andrieu J M, Casassus P, Degos L, et al. Burkitt's lymphoma occurring 6 years after Hodgkin's disease. Acta Haematol 1980; 63: 330–332
   PubMed Web of Science ®Google Scholar
• Nassar V H, Jacobs J, Mirra S S, et al. Burkitt cell leukemia following therapy for Hodgkin's disease. Am J Hematol 1982; 12: 73–76
   PubMed Web of Science ®Google Scholar
• Fonatsch C, Burrichter H, Schaadt M, et al. Translocation t(8;2) in peripheral lymphocytes and established lymphoid cell lines from a patient with Hodgkin's disease followed by acute lymphatic leukemia. Int J Cancer 1982; 30: 321–327
   PubMed Web of Science ®Google Scholar
• Henry-Amar M. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease. JNCI 1983; 71: 911–916
   PubMed Web of Science ®Google Scholar
• Sainty D, Horschowski N, Dalivoust P, et al. Leucemie aigue lymphoblastique de type Burkitt survenant 6 ans apres le traitement d'une maladie de Hodgkin. Presse Med 1983; 12: 2699
   PubMedGoogle Scholar
• Sanchez Tres A, Palacio Fuertes MA, Baeta Poderos C, et al. Leucimia linfoblastica tipo Burkitt en enfermedad de Hodgkin en remision. Saugre 1983; 28: 353–357
   Google Scholar
• Krikler S H, Bain G O, Gordon P A. Burkitt cell leukemia following treatment of Hodgkin's disease: Report of a case and review of the literature. Am J Hematol 1984; 17: 203–208
   PubMed Web of Science ®Google Scholar
• Mandelli F, Martelli M, Cimino G, et al. A case of Burkitt lymphoma-L3 ALL with t(8;14) translocation, developed 10 years after Hodgkin's disease. Scand J Haematol 1985; 34: 97–100
   PubMedGoogle Scholar
• Musto P, Lucchi T, Barbieri D, et al. Leucemia acuta linfoblastica L3 in corso di morbodi Hodgkin in remissione: Leukosi primitiva o secondaria?. Rec Prog Med 1985; 76: 194–198
   PubMedGoogle Scholar
• Brenner B, Nagler A, Ben-Arieh Y, et al. Burkitt leukaemia following chemo-radiotherapy in a patient with Hodgkin's disease. Clin Lab Haematol 1986; 7: 163–164
   Google Scholar
• Zandecki M, Dupriez B, Lai J L, et al. Leucemie aigue lymphoblastique a cellules de Burkitt apres maladie de Hodgkin: Etude de deux observations. Nouv Rev Fr Hematol 1987; 29: 365–369
   PubMedGoogle Scholar
• Cahn J Y, Flesch M, Rozenbaum A, et al. Remissionprolongee d' un lymphome de Burkitt stade IV secondaire a une maladie de Hodgkin. Presse Med 1988; 17: 167
   PubMedGoogle Scholar
• Zollino M, Genuardi M, De Santis R, et al. Partial duplication of chromosome 1q preceding the development of an L3 lymphoblastic leukemia with t(8;14), secondary to treatment for Hodgkin's disease. Eur J Haematol 1988; 40: 193–197
   PubMed Web of Science ®Google Scholar
• Robinson A C, Khoury G O, Carney D. Burkitt's lymphoma in a patient previously treated for Hodgkin's disease. Br J Radiol 1989; 62: 1089–1090
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, et al. Proposals for the classification of the acute leukemias. Br J Haemalol, 33: 451–458, 1076
   Google Scholar
• Wilson W H, Bryant G, Bates S, et al. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993; 11: 1573–1582
   PubMed Web of Science ®Google Scholar
• McMaster M L, Greer J P, Greco F A, et al. Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief duration chemotherapy. J Clin Oncol 1991; 9: 941–996
   PubMed Web of Science ®Google Scholar
• Tucker M A, Coleman C, Cox R, et al. Risk of second cancers after treatment of Hodgkin's disease. N Engl J Med 1988; 318: 76–81
   PubMed Web of Science ®Google Scholar
• Abrahamsen J F, Andersen A, Hannisdal E. Second Malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time and age. J Clin Oncol 1993; 11: 255–261
   PubMed Web of Science ®Google Scholar
• Krikorian J G, Burke J S, Rosenberg S A, et al. Occurrence of non-Hodgkin's lymphoma after treatment of Hodgkin's disease. N Engl J Med 1979; 300: 452–458
   PubMed Web of Science ®Google Scholar
• Jacquillat C, Khayat D, Desprez-Curely J P, et al. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Cancer 1984; 53: 459–462
   PubMed Web of Science ®Google Scholar
• Tester W, Kinsella T, Waller B, et al. Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute experience. J Clin Oncol 1984; 2: 762–769
   PubMed Web of Science ®Google Scholar
• List A F, Greer J P, Cousar J B, et al. Non-Hodgkin's lymphoma after treatment of Hodgkin's disease. Ann Intern Med 1986; 105: 668–673
   PubMed Web of Science ®Google Scholar
• Somers R, Henry-Amar M, Meerwaldt J T, et al. Treatment strategies in Hodgkin's disease. Colloque INSERM/John Libbey Eurotext Ltd. 1990; 196: 357–379
   Google Scholar
• Dietrich P Y, Henry-Amar M, Cosset J M, et al. Second primary cancers in patients continuously free from Hodgkin's disease: A protective role of the spleen?. Blood 1994; 84: 1209–1215
   PubMed Web of Science ®Google Scholar
• Soussain C, Patte C, Ostronoff M, et al. Small noncleaved cell lymphoma and leukemia in adults: A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 1995; 85: 664–674
   PubMed Web of Science ®Google Scholar